Molecular mechanisms of immune suppressive microenvironment in the cornea

Cornea

Volumn 28, Issue SUPPL. 1, 2009, Pages

  Hori, Junko ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Anterior chamber; Apoptosis; Associated immune deviation (ACAID); B7 H1; Corneal transplantation; Immune privilege

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; CORNEA; CORNEA TRANSPLANTATION; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 76449087339     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181ae9b8b     Document Type: Conference Paper

References (46)

1. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003;3:879-889.
2. Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Rev Immunol. 2006;7:354-359.
3. Hori J, Streilein JW. Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epithelium. Invest Ophthalmol Vis Sci. 2003;44:658-664.
4. Medawar PB. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol. 1948;29:58-69.
5. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol. 1977;25:1-54.
6. Hori J. Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation. J Ocul Biol Dis Inform. 2008;1:94-100.
7. Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature. 1979;282:326-327.
8. Sosnova M, Bradl M, Forrester JV. CD34+ corneal stromal cells are bone marrow-derived and express hemopoietic stem cells markers. Stem Cells. 2005;23:507-515.
9. Hamrah P, Zhang Q, Liu Y, et al. Novel characterization of MHC class IInegative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci. 2002;43:639-646.
10. Whitsett CF, Stulting RD. The distribution of HLA antigens on human corneal tissue. Invest Ophthalmol Vis Sci. 1984;25:519-524.
11. Wang HM, Kaplan HJ, Chan WC, et al. The distribution and ontogeny of MHC antigens in murine ocular tissue. Invest Ophthalmol Vis Sci. 1987; 28:1383-1389.
12. Treseler PA, Sanfilippo F. The expression of major histocompatibility complex and leukocyte antigens by cells in the rat cornea. Transplantation. 1986;41:248-252.
13. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice-evidence that the immunogeneic rules of rejection do not apply. Transplantation. 1992;54:694-704.
14. Streilein JW, Arancibia CC, Osawa H. Inadequate HLA matching in keratoplasty. In: Sundmacher R, ed. Developmental Ophthalmology. Basel, Switzerland: Karger AG; 2003:74-88.
15. Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allograft. J Immunol. 1993;150: 1727-1734.
16. Kaplan HJ, Streilein JW. Immune response to immunization via the anterior chamber of the eye. I. F1 lymphocyte-induced immune deviation. J Immunol. 1977;118;809-814.
17. Willbanks GA, Mammolenti MM, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-b2. Eur J Immunol. 1992;22:165-173.
18. Sheibani N, Sorenson CM, Cornelius LA, et al. Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia. Biochem Biophys Res Commun. 2000;267:257-268.
19. Willbanks GA, Streilein JW. Studies on the induction of anterior chamberassociated immune deviation (ACAID). 1. Evidence that an antigenspecific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol. 1991;146:2610-2617.
20. Wang Y, Goldschneider I, O'Rourke J, et al. Blood mononuclear cells induce regulatory NKT thymocytes in anterior chamber-associated immune deviation. J Leukoc Biol. 2001;69:741-746.
21. Faunce DE, Sonoda K-H, Stein-Streilein J. MIP-2 recruits NKT cells on the spleen during tolerance induction. J Immunol. 2001;166:313-321.
22. Sonoda K-H, Exley M, Snapper S, et al. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immuneprivileged site. J Exp Med. 1999;190:1215-1226.
23. + T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol. 2002;169:31-38.
24. Sonoda K-H, Faunce DE, Taniguchi M, et al. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol. 2001;166:42-50.
25. D'Orazio TJ, Niederkorn JY. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology. 1998;95:47-55.
26. Skelsey ME, Mayhew E, Niederkorn JY. Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci. 2003;44:5242-5251.
27. Skelsey ME, Mayhew E, Niederkorn JY. CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology. 2003; 110:18-29.
28. Nakamura T, Sonoda K-H, Faunce DE, et al. CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune privileged site. J Immunol. 2003;171:1266-1271.
29. Niederkorn JY, Mellon J. Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci. 1996;37: 2700-2707. (Pubitemid 27026555)
30. Sonoda K-H, Taniguchi M, Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol. 2002;168:2028-2034.
31. Namba K, Kitaichi K, Nishida. N, et al. Induction of regulatory T cells by the immunomodulating cytokines a-melanocyte-stimulating hormone and transforming growth factor-b2. J Leukoc Biol. 2002;72:946-952.
32. Taylor AW, Yee DG, Streilein JW. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest Ophthalmol Vis Sci. 1998;39:1372-1378.
33. Apte RS, Sinha D, Mayhew E, et al. Role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol. 1998;160:5693-5696.
34. Kennedy MC, Rosenbaum JT, Brown J. Novel production of interleukin-1 receptor antagonist peptides in normal human cornea. J Clin Invest. 1995; 95:82-88.
35. Shon JH, Kaplan HJ, Suk HJ, et al. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest Ophthalmol Vis Sci. 2000;41:4195-4202.
36. Griffith TS, Brunner T, Fletcher SM, et al. FAS ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189-1192.
37. Hori J, Joyce NC, Streilein JW. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule. Invest Ophthalmol Vis Sci. 2000;41:443-452.
38. Hori J, Joyce NC, Streilein JW. Immune privilege and immunogenicity reside among layers of the mouse cornea. Invest Ophthalmol Vis Sci. 2000;41:3032-3042.
39. Sugita S, Streilein JW. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2003;198:161-171.
40. Hori J, Wang MC, Miyashita M, et al. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol. 2006; 177:5928-5935.
41. Dong H., Zhu G, Tamada K, et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 1999;5:1365-1369.
42. Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8:793-800.
43. Dong H, Zhu G, Koji T, et al. B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes. Immunity. 2004;20:327-336.
44. Taniguchi H, Hori J,Wang MC, et al. Role of B7-H3 on immune privilege of corneal allografts. Proc Jpn Soc Immunol. 2007;37:115.
45. Hori J, Wang MC, Taniguchi H, et al. GITR-ligand-induced regulatory T cells as a mechanism of immune privilege of corneal allografts. Proc Jpn Soc Immunol. 2007;37:62.
46. Hori J, Niederkorn JY. Corneal transplantation and immune privilege. Treatment of immune mediated ocular diseases, immune response and the eye. In: Niederkorn JY, Kaplan HA, eds. Chemical Immunology and Allergy. Basel, Switzerland: Karger AG; 2007:290-299.